The incidence of cardiac ischemia varies according to the class of agents: 1–5% with antimicrotubule agents, 2–3% with small-molecule VEGF and TKIs, and 0.6–1.5% with VEGF monoclonal antibodies. The gene discussed is VEGFA; the disease is myocardial ischemia.